Hara Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.01M Sell
2,669
-312
-10% -$109K 0.48% 50
2026
Q2
$875K Sell
2,981
-5
-0.2% -$1.42K 0.46% 54
2026
Q1
$832K Buy
2,986
+183
+7% +$52.7K 0.42% 58
2025
Q4
$849K Sell
2,803
-452
-14% -$141K 0.47% 52
2025
Q3
$913K Buy
+3,255
New +$886K 0.54% 42

Other funds holding BIO

Hara Capital's BIO Position: Q3 2026 in Review

Hara Capital reduced its Bio-Rad Laboratories Class A (BIO) stake by 10% in Q3 2026, selling an estimated $109K and leaving 2,669 shares worth $1.01M. The position accounts for 0.48% of the portfolio, ranked #50.

Hara Capital first reported a position in BIO in Q3 2025 and has held it in 5 quarters since. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Hara Capital held 2,669 shares of Bio-Rad Laboratories Class A worth $1.01M as of Q3 2026.
  • Hara Capital sold 312 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $109K.
  • Bio-Rad Laboratories Class A made up 0.48% of Hara Capital's portfolio in Q3 2026, its #50 holding.
  • Hara Capital first reported a position in Bio-Rad Laboratories Class A in Q3 2025 and has held it in 5 quarters since.
  • 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Hara Capital's 13F filing for Q3 2026, filed 30 Oct 2026.